Health Canada reviewing AstraZeneca antibody drug to prevent symptomatic COVID-19
OTTAWA — AstraZeneca has asked Health Canada to review a new long-acting antibody combination that could be used to prevent symptomatic COVID-19. If approved, it would be the first antibody protection of its kind in Canada. The company says its clinica...




